找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Delivery System; Kewal K. Jain Book 2014Latest edition Springer Science+Business Media, New York 2014 chemical engineering.drug deliv

[復制鏈接]
樓主: Fibromyalgia
51#
發(fā)表于 2025-3-30 08:53:34 | 只看該作者
EDV / Ultraschall / Chordozenteseenhancing drug delivery to the brain is of great importance in diagnostics and therapeutics of central nervous system (CNS) diseases. In this context, nanoparticles are an emerging class of drug delivery systems that can be easily tailored to deliver drugs to various compartments of the body, includ
52#
發(fā)表于 2025-3-30 16:27:41 | 只看該作者
53#
發(fā)表于 2025-3-30 18:29:24 | 只看該作者
Vorposten der Gesundheitspflegeme. There is currently no cure available for any neurodegenerative disease, and the existing therapeutic interventions only alleviate the symptoms of the disease. The advances in the drug discovery research have come to a halt with a lack of effective means to deliver drugs at the targeted site. In
54#
發(fā)表于 2025-3-30 20:49:45 | 只看該作者
55#
發(fā)表于 2025-3-31 02:11:12 | 只看該作者
56#
發(fā)表于 2025-3-31 06:16:05 | 只看該作者
57#
發(fā)表于 2025-3-31 10:32:22 | 只看該作者
58#
發(fā)表于 2025-3-31 14:41:25 | 只看該作者
59#
發(fā)表于 2025-3-31 19:31:52 | 只看該作者
Microfluidic-Based Manufacture of siRNA-Lipid Nanoparticles for Therapeutic Applications,s. In this chapter we describe a novel microfluidic-based manufacturing process for the rapid manufacture of siRNA-LNP, together with protocols for characterizing the size, polydispersity, RNA encapsulation efficiency, RNA concentration, and total lipid concentration of the resultant nanoparticles.
60#
發(fā)表于 2025-3-31 22:16:53 | 只看該作者
https://doi.org/10.1007/978-3-662-37803-8Recent studies have shown the ability of mesenchymal stem cells (MSCs) to migrate toward and engraft into the tumor sites, which provides a potential for their use as carriers for cancer gene therapy. Here, we describe the strategies of using MSCs as carriers for cancer gene therapy using a nonviral transfection method.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 10:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
华亭县| 集安市| 奇台县| 泰州市| 济阳县| 多伦县| 乾安县| 常州市| 图木舒克市| 夏河县| 田东县| 靖州| 揭阳市| 屯留县| 汉源县| 驻马店市| 吉木萨尔县| 宝应县| 班玛县| 安溪县| 富宁县| 营口市| 玉林市| 伊宁县| 崇文区| 贵溪市| 阳西县| 台湾省| 囊谦县| 河北区| 涟水县| 奉节县| 科技| 唐山市| 金华市| 潍坊市| 贺州市| 鄢陵县| 秭归县| 蚌埠市| 广昌县|